BillionToOne, Inc. (BLLN)
NASDAQ: BLLN · Real-Time Price · USD
111.64
+7.62 (7.33%)
At close: Dec 5, 2025, 4:00 PM EST
112.00
+0.36 (0.32%)
After-hours: Dec 5, 2025, 7:52 PM EST
BillionToOne Revenue
BillionToOne had revenue of $125.54M in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to $209.03M. In the year 2024, BillionToOne had annual revenue of $152.58M with 112.72% growth.
Revenue (ttm)
$209.03M
Revenue Growth
+112.72%
P/S Ratio
5.47
Revenue / Employee
$337,148
Employees
620
Market Cap
5.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 152.58M | 80.85M | 112.72% |
| Dec 31, 2023 | 71.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBLLN News
- 3 days ago - BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - GlobeNewsWire
- 4 days ago - Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally - Benzinga
- 4 days ago - BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - Reuters
- 4 weeks ago - BillionToOne: A Deserved Opening Day Boom - Seeking Alpha
- 4 weeks ago - Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering - PRNewsWire
- 4 weeks ago - BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut - Reuters
- 4 weeks ago - Molecular diagnostics firm BillionToOne raises $273 million in US IPO - Reuters
- 4 weeks ago - BillionToOne Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire